Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant. (2021)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.immuni.2021.03.023
PubMed Identifier: 33836142
Publication URI: http://europepmc.org/abstract/MED/33836142
Type: Journal Article/Review
Volume: 54
Parent Publication: Immunity
Issue: 6
ISSN: 1074-7613